Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: A multicenter prospective randomized study

Journal of Investigative Medicine

Volumn 61, Issue 5, 2013, Pages 872-877

  Koc, Fatih ^a   Ozdemir, Kurtulus ^b   Altunkas, Fatih ^a   Celik, Atac ^a   Dogdu, Orhan ^c   Karayakali, Metin ^a   Gul, Enes Elvin ^b   Erkorkmaz, Unal ^d   Kadi, Hasan ^a   Akpek, Mahmut ^c   Kaya, Mehmet Gungor ^c  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

^d SAKARYA UNIVERSITY   (Turkey)

Author keywords

Contrast induced nephropathy; Diabetes mellitus; Isotonic saline; Sodium bicarbonate

Indexed keywords

BICARBONATE; CONTRAST MEDIUM; CREATININE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; URINE PH;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DIABETES MELLITUS; ENDPOINT DETERMINATION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOTONIC SOLUTIONS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 84880291686     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31828e9cab     Document Type: Article

References (40)

1. Marenzi G, Assanelli E, Marana I., et al N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006; 354:2773-2782.
2. Barrett BJ, Parfrey PS Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006; 354:379-386.
3. Russo D, Minutolo R, Cianciaruso B., et al Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol. 1995; 6:1451-1458.
4. Katholi RE, Woods WT Jr, Taylor GJ, et al Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998; 32:64-71.
5. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agentYinduced reductions in renal function by acetylcysteine. N Engl J Med. 2000; 343:180-184.
6. Briguori C, Airoldi F, D'Andrea D, et al Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007; 115: 1211-1277.
7. Mueller C, Buerkle G, Buettner H.J., et al Prevention of contrast associated nephropathy. Arch Intern Med. 2002; 162:329-336.
8. Kshirsagar AV, Poole C, Mottl A., et al N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol. 2004; 15:761-769.
9. Pannu N, Manns B, Lee H., et al Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004; 65:1366-1374.
10. Ozcan EE, Guneri S, Akdeniz B., et al Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007; 154:539-544.
11. Brar SS, Shen AY, Jorgensen M.B., et al Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008; 300:1038-1046.
12. Merten GJ, Burgess WP, Gray L.V., et al Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291:2328-2334.
13. Jo SH, Koo BK, Park J.S., et al N-acetylcysteine versus ascorbic acid for preventing contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. Am Heart J. 2009; 157:576-583.
14. Pflueger A, Larson TS, Nath K.A., et al Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000; 75:1275-1283.
15. Pflueger A, Abramowitz D, Calvin AD Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus. Med Sci Monit. 2009; 15:125-136.
16. Barrett BJ, Parfrey PS, Vavasour H.M., et al Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992; 41:1274-1276.
17. Cockcroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
18. Jo SH, Koo BK, Park J.S., et al Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study. Am Heart J. 2008; 155:499.e1-449.e8.
19. Kunadian V, Zaman A, Spyridopoulos I., et al Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol. 2011l; 79:48-55.
20. Weisbord SD, Palevsky PM Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol. 2008; 3:273-280.
21. Kanbay M, Covic A, Coca S.G., et al Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol. 2009; 41:617-627.
22. Tamura A, Goto Y, Miyamoto K., et al Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. Am J Cardiol. 2009; 104:921-925.
23. Maioli M, Toso A, Leoncini M., et al Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol. 2008; 52:599-604.
24. Lee SW, Kim WJ, Kim Y.H., et al Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial). Am J Cardiol. 2011; 107:1447-1452.
25. Koc F, Ozdemir K, Kaya M.G., et al Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASISVA multicenter prospective controlled trial. Int J Cardiol. 2012; 155:418-423.
26. Krasuski RA, Beard BM, Geoghagan J.D., et al Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol. 2003; 15:699-702.
27. Bader BD, Berger ED, Heede M.B., et al What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol. 2004; 62:1-7.
28. 2/bicarbonate and hydrogen peroxide. Free Radic Biol Med. 2003; 35:1538-1550.
29. Diaz-Sandoval L.J., Kosowsky BD, Losordo DW Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002; 89:356-358.
30. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002; 40:1383-1388.
31. Briguori C, Colombo A, Violante A., et al Standard vs double dose of N-acetylcysteine to prevent contrast agent-associated nephrotoxicity. Eur Heart J. 2004; 25:206-211.
32. Coyle LC, Rodriguez A, Jeschke R.E., et al Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J. 2006; 151:1032.e9-e12.
33. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172:1461-1471.
34. Aspelin P, Fransson SG, Strasser R, et al Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348:491-499.
35. Chalmers N. Comparison of iodixanol and iohexol in renal impairment. Randomized controlled trial. Br J Radiol. 1999; 72:701-703.
36. Liss P, Hansell P, Lagerqvist B. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006; 70:1811-1817.
37. Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high-risk patients. Kidney Int. 2005; 68:2256-2263.
38. Solomon RJ, Doucet S, Sharma A.K., et al Cardiac Angiography in Renally Impaired Patients (CARE) Study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007; 115:3189-3196.
39. Schmidt P, Pang D, Nykamp D., et al N-Acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother. 2007; 41:46-50.
40. Pakfetrat M, Nikoo MH, Malekmakan L, et al A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. Int Urol Nephrol. 2009; 41:629-634.